Prednisone trials for Prostate cancer

All Prednisone trials · All Prostate cancer trials

Phase breakdown

Recruiting trials studying Prednisone for Prostate cancer

• A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
  NCT06925737 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 298 locations
• A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
  NCT07005154 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 54 locations
• A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer
  NCT04633252 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 110 Years · Sex: Male · 1 location
• A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
  NCT04729114 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · 25 locations
• A Study to Evaluate the Safety and Drug Levels of ASP5541 in Chinese Participants With Prostate Cancer
  NCT07339267 · Phase: Phase 1 · Ages: 18 Years to 85 Years · Sex: Male · 1 location
• Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer
  NCT07237269 · Phase: Phase 2 · Ages: 30 Years and older · Sex: Male · 1 location
• Abiraterone and Prednisone or Darolutamide for the Treatment of Advanced Prostate Cancer
  NCT06173362 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer
  NCT04947254 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostate Cancer
  NCT03833921 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 3 locations
• Hyperpolarized (HP) 13C Pyruvate Magnetic Resonance Imaging (MRI) for Response Monitoring to Neoadjuvant Abiraterone
  NCT06384222 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study
  NCT04175431 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 2 locations
• REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial
  NCT06650579 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 4 locations
• Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
  NCT03678025 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 338 locations
• Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial
  NCT06378866 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 3 locations
• Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
  NCT06136624 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 288 locations
• Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
  NCT05176483 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 244 locations
• Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)
  NCT06353386 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 77 locations
• Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer
  NCT04734730 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
  NCT06470243 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 174 locations

Common questions

How many trials study Prednisone for Prostate cancer?

19 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.